Cytek Biosciences Inc (NAS:CTKB)
$ 6.39 -0.14 (-2.14%) Market Cap: 841.13 Mil Enterprise Value: 572.72 Mil PE Ratio: 0 PB Ratio: 2.20 GF Score: 60/100

Q3 2024 Cytek Biosciences Inc Earnings Call Transcript

Nov 05, 2024 / 09:30PM GMT
Release Date Price: $5.44 (+4.62%)
Operator

Thank you for standing by. At this time, I'd like to welcome everyone to the Cytek Biosciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to rejoin your question again, press the star one. I will now turn the conference over to Paul Goodson, Head of Investor Relations. Paul, please go ahead.

Paul Goodson
Cytek Biosciences, Inc. - Head of Investor Relations

Thank you, operator. Earlier today, Cytek Biosciences released financial results for the quarter ended September 30th, 2024. If you have not received this news release or if you'd like to be added to the company's distribution list, please send an email to [email protected]. Joining me today from Cytek are Wenbin Jiang, CEO; and William McCombe, CFO.

Before we begin, I'd like to remind you that management will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot